RAPHAEL PHARMACEUTICAL ANNOUNCES POSITIVE PROOF-OF-CONCEPT CLINICAL STUDY RESULTS FOR THE COMPANY’S CANNABINOID-BASED FORMULA FOR THE TREATMENT OF RHEUMATOID ARTHRITIS

Reuters · 01/07 13:00

Please log in to view news